Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population

Internal Medicine

Volumn 47, Issue 21, 2008, Pages 1859-1864

  Yoshida, Takumi ^a   Takei, Takashi ^a   Shirota, Satsuki ^a   Tsukada, Misao ^a   Sugiura, Hidekazu ^a   Itabashi, Mitsuyo ^a   Ogawa, Tetsuya ^a   Uchida, Keiko ^a   Tsuchiya, Ken ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; GFR; Hyperlipidemia; Hypertension; Proteinuria; Smoking

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN A; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; PROTEINURIA; RISK FACTOR; SMOKING HABIT; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 56349111391     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1171     Document Type: Article

References (26)

1. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11: 156-163, 2007.
2. Stengel B, Billon S, Van Dijk PC, et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 18: 1824-1833, 2003.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
4. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003.
5. Imai E, Horio M, Nitta K, et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 50: 927-937, 2007.
6. Vikse BE, Bostad L, Aasarod K, et al. Prognostic factors in mesangioproliferative glomerulonephritis. Nephrol Dial Transplant 17: 1603-1613, 2002.
7. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
8. Omae K, Ogawa T, Nitta K. Risk factors for deterioration of renal function in chronic glomerulonephritis: Multivariate analysis of risk factors at various disease stage in patients with chronic kidney disease. Junkankika 62: 195-202, 2007 (in Japanese).
9. Ruggenenti P, Perna A, Mosconi L, et al. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 53: 1209-1216, 1998.
10. Yamagata K, Iseki K, Nitta K, et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol 12: 1-8, 2008.
11. Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 7: 2627-2635, 1996.
12. Orth SR, Stockmann A, Conradt C, et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54: 926-931, 1998.
13. Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens 11: 483-488, 2002.
14. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients - absence of evidence or evidence of absence? Clin J Am Soc Nephrol 3: 226-236, 2008.
15. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997.
16. Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58: 293-301, 2000.
17. Iseki K, Tozawa M, Ikemiya Y, et al. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort. Clin Exp Nephrol 9: 46-52, 2005.
18. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330: 877-884, 1994.
19. Fofi C, Pecci G, Galliani M, et al. IgA nephropathy: multivariate statistical analysis aimed at predicting outcome. J Nephrol 14: 280-285, 2001.
20. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 18: 503-512, 2005.
21. Komatsu H, Fujimoto S, Hara S, et al. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Ren Fail 27: 45-52, 2005.
22. Morita S, Fukuhara S, Akizawa T, et al. Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease. Ther Apher Dial 10: 72-77, 2006.
23. Praga M. Obesity - a neglected culprit in renal disease. Nephrol Dial Transplant 17: 1157-1159, 2002.
24. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876, 2004.
25. Tanaka H, Shiohira Y, Uezu Y, et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69: 369-374, 2006.
26. Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 48: 383-391, 2006.